| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |